The Voice of Epidemiology

    
    


    Web EpiMonitor

► Home ► About ► News ► Jobs ► Events ► Resources ► Contact

Keynotes

Humor Quotes Wit & Wisdom EpiSource Miscellany Editor's Tips Triumphs Links Archives
 


Epi Wit & Wisdom Articles

NY Times Editorial Critical of Tort Lawyers Who Disregard Epidemiological Evidence

[Ed. Reprinted below is a March 24, 1985 New York Times editorial of interest to all who gather epidemiologic evidence.]

The Cause and Defect of Orangemail

The case of the morning sickness drug Bendectin shows how the American legal system has twisted itself into a contradiction on cases involving science and health. There are more and bigger such cases ahead and unless something is done, there will be more contortions.

Bendectin Example

A Federal jury in Cincinnati decided last week that Bendectin is not the cause of birth defects. That accords with the best available scientific evidence. But consider how narrowly, and at what cost, the legal system cranked out the same verdict.

From more than 20 epidemiological studies, the Food and Drug Administration believes Bendectin is safe. There’s no evidence that it increases the natural rate of birth defects. But personal injury lawyers have another calculus to work with: a jury’s heart will go out to individual suffering, particularly a deformed child and its parents.

The first Bendectin case brought against the drug’s maker, Merrell-Dow, perfectly reflected the juror’s torment. They ruled that the child’s injuries were not caused by the drug, but awarded the parents $20,000 for medical expenses anyway. The company won on retrial. In the second case, a jury awarded $750,000 but was reversed by the judge.

Despite these results, each trial stimulated a flood of new claims. The company offered to set up a $120 million fund to pay all present and future claimants. To settle after or in anticipation of losses is reasonable. But the costs of justice have become absurdly excessive when defendants feel compelled to settle after they have won.

Yet some of the plaintiffs’ lawyers wanted even more than $120 million. They got the settlement overturned and went back to court. Now District Judge Carl Rubin in Cincinnati took the unusual step of separating the issues. First, the jury was to decide if Bendectin was a cause of birth defects, and only if so, what the liability and damages should be. He also ruled that the damaged children be kept out of the jury’s sight. The jury concluded Bendectin was not a cause of birth defects.

The System

Personal injury lawyers work for a contingency fee, taking a sizable share of any damages but getting nothing if the case is lost. That’s the only way many plaintiffs can get their cases brought. But it encourages lawyers to make multiple claims: extra cases need little extra preparation, yet each promises the same high premium fee as the first.

Both with Bendectin and Agent Orange, the herbicide used in Vietnam, the available scientific evidence speaks formidably against a causative link to injuries. Still in both cases hundreds of attorneys were prepared to sue, presumably believing that in the juror’s mind a parade of pitiful injuries would outweigh the abstract evidence of epidemiology.

Orangemail

The costs of fighting such a mass of suits drives the defendant toward settlement. The makers of Agent Orange, or their insurers, paid $180 million rather than face interminable litigation-orange-mailed by the threat of the law’s costs and of juries’ preference for compassion over dispassion. Merrell-Dow would have paid $120 million in orangemail had not the opposing lawyers tried to shake it down still harder.

Even in cases where a substance clearly causes injury, like asbestos, lawyers end up with a disproportionate share of the damages. Who ultimately bears this cost? Consumers do, since manufacturers, faced with higher liability insurance, mark up their products or, as in the case of certain vaccines, simply cease production.

Neither plaintiffs nor defendants have cause for happiness with such a system. Its defects are significant because other cases waiting in the wings, involving toxic dumps and industrial chemicals, are likely to raise similar problems.

Powerful remedies are open to the judges who oversee such cases. Sharply reducing fees, as Judge Weinstein did with Agent Orange, restores attorneys’ risk to the level that justifies their high contingency fees. Making causation and damages separate issues, as Judge Rubin did with Bendectin, helps juries separate science from sentiment. By following these creative examples, judges can save the legal system from the contortions in which tort lawyers have tied it.

Published May 1985  v

 

 
      ©  2011 The Epidemiology Monitor

Privacy  Terms of Use  |  Sitemap

Digital Smart Tools, LLC